Summary of this blog
- Healthcare AI marketing has a new problem: the word AI no longer earns trust in health, it asks for it. A clinician, a regulator and a security officer each read an AI claim as a question, and the page either answers it or loses them.
- The scrutiny is real. The FTC launched Operation AI Comply in September 2024 with five enforcement actions and the line “there is no AI exemption from the laws on the books”; the FDA maintains a public list of AI-enabled medical devices updated through June 2026; the WHO’s guidance on large multi-modal models names false or biased outputs and automation bias as risks.
- Eight rules: say what the AI does and does not; state the regulatory status first; show the validation rather than the demo; keep the clinician in the loop on the page; be plain about the data; stay inside the FTC line; name the humans behind the model; and measure trust as a conversion metric.
- The buyer is using AI too. KFF found 32% of US adults have turned to AI tools for health information, and professional buyers use the same tools to research vendors, so the claim is read by people who know what the technology can and cannot do.
- Rewrite the AI product’s pages in the order a sceptic reads them: the regulatory status and the validation before the benefits.
Healthcare AI marketing has a problem it did not have three years ago. The word AI no longer earns trust in health; it asks for it. A clinician reads “AI-powered” and wonders what the model was validated on. Then a hospital security officer reads it and wonders where the patient data goes. And a regulator reads it and wonders whether the claim is supported. Every health product now says AI, and the page that keeps trust is the one that answers all three questions before making a single promise.
The scrutiny is real and recent. In September 2024 the FTC launched Operation AI Comply, five enforcement actions against companies using AI claims to mislead, with the line “there is no AI exemption from the laws on the books”. The FDA maintains a public list of AI-enabled medical devices, updated through June 2026. The WHO’s guidance on large multi-modal models names false, biased or incomplete outputs and automation bias among the risks. The buyer has read all three, and healthcare AI marketing is written for a reader who has.
This guide sets out eight healthcare AI marketing rules for the founder or marketing lead at a company whose product uses AI, whether as a regulated device, as clinical decision support, or as administrative automation. Our pillar on HealthTech go-to-market strategy covers the commercial plan the positioning sits inside, and our guide to MedTech messaging strategy covers speaking to clinicians and procurement at once.
The word AI no longer earns trust in health; it asks for it. Healthcare AI marketing that keeps trust says what the model does, what it has been shown to do, and who is still responsible.
The three-reader test
Give the product page to a clinician, a security officer and someone who has read the FTC guidance, and ask each what question the page left unanswered. Healthcare AI marketing that passes the test has answered the model’s purpose, its validation, its regulatory status, its data handling and its human oversight before the first benefit statement. Most pages answer none of them and lead with the benefit.
1. Say what the AI does, and does not
The first rule is precision. “AI-powered” describes nothing. Healthcare AI marketing says what the model takes in, what it produces, and what it does not do: “reads the discharge summary and drafts the coding, which a coder reviews” or “flags the referrals most likely to be urgent for a clinician to triage first”. Then the boundary: what the model is not designed to do and where it hands back to a person. A boundary stated plainly is the first thing a clinician trusts.
The rewrite
Before: “Our AI transforms clinical workflows with intelligent automation.” After: “The model reads the referral letter and suggests a priority, with the three sentences it based the suggestion on. A clinician confirms or changes it. The model does not make the decision and does not see the patient’s wider record.” Three sentences of healthcare AI marketing, and the clinical seat knows what she is being asked to trust.
2. State the regulatory status first
The second rule is the line the IT seat and the clinical safety officer look for before anything else. Is the product a regulated medical device, and if so under which pathway, or is it outside the device definition, and on what basis? The FDA’s list of AI-enabled medical devices records each authorisation by pathway, 510(k), De Novo or PMA, and a hospital buyer checks it. Healthcare AI marketing puts the status in the first screen, in one sentence, with the number where there is one.
The rewrite
Before: nothing, or a footer disclaimer. After: “Cleared by the FDA under 510(k) as a Class II device for the triage of chest radiographs; UKCA-marked Class IIa; not intended for use outside those indications.” Or, where the product is administrative: “Not a medical device: the software drafts documentation for a clinician’s review and makes no clinical determination.” Either is a healthcare AI marketing position. Silence is a question.
3. Show the validation rather than the demo
The third rule is evidence. A demo shows the model on a case the vendor chose. Validation shows it on cases it did not choose: the population, the sites, the sample size, the performance measures, the comparison with clinicians, the failure modes. Healthcare AI marketing publishes the validation summary on the product page with a named author and a link to the full study, because the clinical seat will not book a demo of a model whose validation she cannot read.
What the validation page carries
The question the study asked. Then the population and the settings, so a buyer can see whether her patients resemble them, and the sample. Measures next, with sensitivity and specificity where they apply, and the confidence intervals. A comparison, against clinicians or against the prior standard. Finally the limitations, in the authors’ words, because healthcare AI marketing that hides them is read as marketing. Google’s guidance on helpful content weights experience and expertise more heavily on health topics, and a validation page with a named clinical author is what ranks for the buyer’s most serious searches.
4. Keep the clinician in the loop on the page
The fourth rule answers the WHO’s named risk. Automation bias, the tendency to accept a machine’s suggestion without checking it, is the reason clinical safety officers hesitate over AI products, and the reason many implementations fail after go-live. Healthcare AI marketing shows the human in the loop on the page: where the clinician confirms, what she sees when she does, how the model shows its reasoning, and how a disagreement is recorded. A product that hides the human step to look more automated has lost the safety officer.
The rewrite
Before: “Fully automated triage.” After: “The model suggests a priority and shows the sentences it relied on. The clinician confirms, changes or rejects it in one click, and every change is logged and fed back to the model’s monitoring. Nothing reaches the patient list without a clinician’s confirmation.” The second version is slower to read and faster to approve, which is the healthcare AI marketing trade every time.
A specialist’s view on your AI product pages
Want the three-reader test run on your pages?
Book a free consultation with Healthora. We’ll read your AI product’s pages with you as a clinician, a security officer and a regulator read them, tell you candidly where the trust leaks, and share rewrites you can apply immediately, whether you decide to work with us or not.
Book a Free Consultation5. Be plain about the data
The fifth rule is the security officer’s question. What data trained the model, whose data does it process now, where is it held, is it used to retrain, and can the customer opt out. Healthcare AI marketing answers all five on the security page and in one line on the product page, because a hospital’s information governance review will ask them in exactly that form. In the US, the HHS guidance on online tracking technologies is a reminder that even the marketing site’s scripts are part of the review.
The five-line data statement
Trained on: the datasets, de-identified, with the consent basis. Processes: the customer’s data, under the agreement, in the named regions. Retraining: only with the customer’s written opt-in, or never. Retention: the period, and the deletion process. Sub-processors: listed, with a change notice. Five lines the security officer can copy into her review, and healthcare AI marketing that provides them has saved her a fortnight of email.
6. Stay inside the FTC line
The sixth rule is the regulator’s. The FTC’s Operation AI Comply established that AI claims are held to the same standard as any other, and the FTC’s Health Products Compliance Guidance requires “competent and reliable scientific evidence” for health claims. The FTC’s 2024 rule on consumer reviews also bans AI-generated reviews and testimonials, which closes the shortcut some AI vendors were tempted by. Healthcare AI marketing reads every claim against the validation before it is published.
The claims check
“Detects cancer earlier” needs a study that shows it. “Reduces documentation time by 40%” needs the measurement, the sites and the baseline. “Clinically validated” needs the validation page. “Physician-approved” needs the physicians, named. Healthcare AI marketing replaces every claim the evidence cannot carry with the claim it can, and put the evidence one click away. A page that would survive the FTC survives the clinical seat.
7. Name the humans behind the model
The seventh rule is the trust the technology cannot supply. A buyer trusts an AI product because of the people who built, validated and monitor it. Healthcare AI marketing names them: the clinical lead who designed the validation, the data science lead who built the model, the clinical safety officer who owns the hazard log, with credentials and real photographs. A model with no named humans behind it is read as a model nobody is accountable for.
The monitoring line
Who watches the model’s performance after go-live, how often, and what happens when it drifts. One paragraph of healthcare AI marketing on the product page, with the named owner. At Healthora, we have seen that AI products which state their post-deployment monitoring on the page tend to reach the clinical safety review with fewer questions outstanding, because the question the safety officer was going to ask first has been answered by the person who will answer it in practice. Our guide to healthcare E-E-A-T covers why the same names decide what ranks.
8. Measure trust as a conversion metric
The eighth rule is how to know whether the seven above are working. Healthcare AI marketing measures trust in the behaviour of the buyer on the site: reads of the validation page and the security page before a demo request, downloads of the data statement, and the objections that appear in the first sales call. When the validation page appears in the path of most demo requests and the “what was it validated on” question stops appearing on the call, the positioning has done its job.
The four trust numbers
The share of demo requests whose path includes the validation page. Then the share that includes the security page. Next, the number of distinct objections raised in the first call, tracked monthly. Last, the share of demo requests sales accepts as qualified, the healthcare AI marketing number the board reads. Gartner reports 75% of B2B buyers prefer a rep-free experience, so the pages are where trust is built or lost, and the numbers say which.
What we see when the numbers are tracked
At Healthora, we have seen that AI products which put the regulatory status, the validation and the data statement ahead of the benefits tend to see a change in who requests the demo: more clinical safety officers and IT leads, fewer curious browsers, and a higher share accepted by sales. KFF’s tracking poll found 32% of US adults have turned to AI tools for health information, and the professional buyer, using the same tools, knows what the technology can and cannot do. Marketing that respects that knowledge converts it.
Healthcare AI marketing in practice: the rewrite in a sceptic’s order
Healthcare AI marketing in practice rewrites the product pages in the order a sceptic reads them. Week one runs the three-reader test and writes the one-sentence regulatory status and the what-it-does-and-does-not statement. Then the second week builds the validation page with its named author and the five-line data statement. Week three draws the human-in-the-loop step on the product page and names the three people behind the model with their monitoring line. The fourth week runs the claims check against the validation, rewrites what fails, and sets up the four trust numbers.
The healthcare AI marketing change shows first in the path to the demo request, where the validation and security pages start appearing, and then in the first sales call, where the questions the pages answered stop being asked. A product that led with “AI-powered” and now leads with its status, its validation and its people is the same product, read by the same three sceptics, and approved by them. Our guide to why HealthTech buyers hesitate covers the objections the eight rules answer.
The recap below lists the eight rules in the order to apply them.
- Say what the AI does, and does not. Inputs, outputs, the boundary, and where it hands back to a person.
- State the regulatory status first. The first line of healthcare AI marketing: device or not, the pathway and the number, or the basis for being outside the definition, in the first screen.
- Show the validation rather than the demo. Population, sites, sample, measures, comparison, limitations, with a named author and a link to the study.
- Keep the clinician in the loop on the page. Where she confirms, what she sees, how the model shows its reasoning, how disagreement is logged.
- Be plain about the data. The healthcare AI marketing data statement: trained on, processes, retraining, retention, sub-processors: five lines the security officer can copy.
- Stay inside the FTC line. Every claim read against the validation, no AI-generated reviews, the evidence one click away.
- Name the humans behind the model. The clinical lead, the data science lead, the safety officer, and who monitors performance after go-live.
- Measure trust as a conversion metric. Validation and security page reads before the request, objections per first call, requests accepted. Healthcare AI marketing is judged here.
The eight healthcare AI marketing rules can be applied by the founding team, by a specialist agency, or by the two together. Our services and case studies show what the positioning and evidence work looks like in engagements we have run, and our guide to AI search for HealthTech covers being cited by the AI tools the buyer now researches with.
A specialist in health understands that the word AI now asks for trust rather than earning it, that the three readers each bring a question, and that the regulator reads the page too. Say what the model does, state the status, show the validation, keep the clinician in the loop, be plain about the data, stay inside the line, name the humans, and measure trust. Then the AI product is positioned by what it has been shown to do.
Ready to position the AI product on what it has been shown to do?
HEALTHORA SPECIALISES IN HEALTH
Book a free consultation with Healthora. We’ll identify where your AI product’s pages lose the clinician, the security officer or the regulator, show you the eight rules in order, and share rewrites you can apply immediately, whether you decide to work with us or not.
Book a Free ConsultationFrequently asked questions
How should a healthcare AI product describe what it does?
In terms of inputs, outputs and boundary: what the model reads, what it produces, what it does not do, and where it hands back to a clinician. “AI-powered” describes nothing. Healthcare AI marketing that states the boundary plainly is the first thing a clinical seat trusts, because it tells her what she is being asked to rely on.
Does an AI health product have to say whether it is a medical device?
Say it first, whatever the answer; that is the healthcare AI marketing rule on status. If it is a device, state the pathway and the number; the FDA’s public list of AI-enabled devices is where a hospital buyer checks. If it is outside the device definition, state the basis: for example, software that drafts documentation for a clinician’s review and makes no clinical determination. Silence reads as a question the vendor did not want to answer.
What is the difference between a demo and validation?
A demo shows the model on a case the vendor chose. Validation, which healthcare AI marketing leads with, shows it on cases it did not: the population, the sites, the sample size, the performance measures with confidence intervals, the comparison with clinicians or the prior standard, and the limitations. Publish the validation summary with a named author and a link to the study; the clinical seat reads it before she books the demo.
What does the FTC require for AI health claims?
The same standard as any other claim, and healthcare AI marketing is held to it: competent and reliable scientific evidence for health claims, under the FTC’s Health Products Compliance Guidance. Operation AI Comply, launched in September 2024 with five enforcement actions, made the point that there is no AI exemption, and the FTC’s 2024 consumer reviews rule bans AI-generated reviews and testimonials. Read every claim against the validation before publishing.
What data questions will a hospital ask about an AI product?
Five: what the model was trained on and under what consent basis; whose data it processes now and in which regions; whether customer data is used to retrain and how to opt out; how long data is retained and how it is deleted; and which sub-processors are involved. Healthcare AI marketing answers all five in a data statement the security officer can copy into her review.
Why does automation bias matter for marketing?
Because the WHO’s guidance on large multi-modal models names it as a risk, healthcare AI marketing has to answer it, and clinical safety officers assess for it. A product page that hides the human step to look more automated loses the safety officer; one that shows where the clinician confirms, what she sees, how the model shows its reasoning and how disagreement is logged is slower to read and faster to approve.
What does Healthora charge for AI product positioning?
Fees depend on scope, from a one-off healthcare AI marketing review against the eight rules to an engagement covering the product pages, the validation page, the data statement and the sales objection sheet, and are agreed for the engagement rather than billed by the hour. The consultation is free and includes the three-reader test.
Keep reading
More on AI and health marketing: